Back to journals
Academic Journal

Lancet

2 Papers Indexed in Blossom

Data updated

Research Footprint

Lancet has 2 tracked papers indexed in Blossom (2023–2024) from 21 authors, most often covering Psilocybin, LSD and MDMA, across Treatment-Resistant Depression (TRD), Depressive Disorders and PTSD.

Published Papers

Paywallmeta

Quality of reporting on psychological interventions in psychedelic treatments: a systematic review

This systematic review (s=45) on psychedelic-assisted psychotherapy for mental disorders finds that psychological interventions are reported with low completeness and high heterogeneity. It also finds that MDMA studies are more homogeneous, with greater procedural detail.

Published
Journal
Lancet
Authors
Seybert, C., Schimmers, N., Silva, L., Breeksema, J. J., Veraart, J. K. E., Bessa, B. S., d'Orsi, D., Schoevers, R. A., Dinis-Oliveira, R. J.
Paywallmeta

The therapeutic potential of psychedelics: the European regulatory perspective

This commentary (2023) showcases the support, and open questions, from the European regulatory perspective. It highlights the difficulties facing psychedelic trials (e.g. blinding), and showcases the support EMA can offer in ensuring the trials get done in a way that will lead to regulatory approval.

Published
Journal
Lancet
Authors
Butlen-Ducuing, F., McCulloch, D. E-W., Haberkamp, M., Mattila, T., Bałkowiec-Iskra, E., Aislaitner, G., Balabanov, P., Lundberg, J., Stenbæk, D. S., Elferink, A., Knudsen, G. M., Thirstrup, S.

Quick Facts

Papers Indexed
2
Publisher
Elsevier
Website
Visit